Post-COVID Factor X Deficiency: A Case Report From Pakistan
Overview
Affiliations
Acquired Factor X deficiency is a rare hematological disease, characterized by excessive bleeding, with fewer than 50 cases reported in the literature and practically all being associated with amyloidosis. We describe a case of a 38-year-old man with no known family history of hematologic disorders who had symptoms of a mild COVID-19 infection. Upon resolution, he developed excessive bleeding features, including epistaxis and hematuria. It was later found that while the rest of the coagulation factors were within normal limits, Factor X was 7% of the normal value, which reversed about two months after recovery. Our case highlights the significance of the less-expected post-COVID bleeding complications, in contrast to the classically seen thrombotic ones.
Case report: a case of AL amyloidosis with spontaneous giant retroperitoneal hematoma.
Sheng Y, Zhu H Int J Emerg Med. 2024; 17(1):200.
PMID: 39731001 PMC: 11674221. DOI: 10.1186/s12245-024-00801-3.
Circulating Inhibitor against Factor X: A Rare Cause of Hemorrhagic Diathesis.
Rossignon P, Grandjean F, Claessens A, Weynants N Case Rep Hematol. 2023; 2023:5510654.
PMID: 38124779 PMC: 10732816. DOI: 10.1155/2023/5510654.
Menakuru S, Dhillon V, Salih A, Beirat A Hematol Rep. 2023; 15(2):312-316.
PMID: 37218824 PMC: 10204373. DOI: 10.3390/hematolrep15020032.